MeSH D009902 - optic neuritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Allergan | Corticotropin | Corticotropin | 1984-11-21 | |||
| ANI Pharmaceuticals | Corticotropin | Cortrophin | 2043-10-27 | 1982-01-01 | ||
| Mallinckrodt | Corticotropin | Acthar | 2041-02-25 | 1982-01-01 | ||
| Organics Lagrange | Corticotropin | Corticotropin | 1982-01-01 | |||
| Parkedale Pharmaceuticals | Corticotropin | Acth | 1982-01-01 | |||
| Sanofi | Corticotropin | Acthar | 1982-01-01 |
Clinical Trials
Historical Success Rate
Phase 1
67%2/3
Phase 2
45%10/22
Phase 3
36%5/14
Approved: 1Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use